Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
01:34:37 EDT Mon 20 May 2024
Enter Symbol
or Name
USA
CA



News for C:RKV from 2023-05-21 to 2024-05-20 - 22 items News ReleasesIn The NewsOther CAUS
DateSymCompanyPriceTypeHeadline
2024-05-08 13:23C:RKVRakovina Therapeutics Inc0.09News ReleaseRakovina expands Deep Docking research partnerships
2024-04-26 22:16C:RKVRakovina Therapeutics Inc0.09SEDAR MD & ASEDAR MD & A
2024-04-26 21:51C:RKVRakovina Therapeutics Inc0.09SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-04-26 20:47C:RKVRakovina Therapeutics Inc0.09News ReleaseRakovina Therapeutics ends 2023 with cash of $436,313
2024-04-19 19:33C:RKVRakovina Therapeutics Inc0.09Shares for DebtRakovina Therapeutics 255,425 shares for debt
2024-04-09 16:18C:RKVRakovina Therapeutics Inc0.09News ReleaseRakovina presents data on kt-3000 series at AACR
2024-04-01 10:16C:RKVRakovina Therapeutics Inc0.10News ReleaseRakovina hires Insight Capital for advisory services
2024-03-27 16:23C:RKVRakovina Therapeutics Inc0.095News ReleaseRakovina signs agreement for Deep Docking AI platform
2023-11-27 19:54C:RKVRakovina Therapeutics Inc0.07News ReleaseRakovina has cash of $813,328 at Sept. 30
2023-11-27 19:07C:RKVRakovina Therapeutics Inc0.07SEDAR Interim MD & ASEDAR Interim MD & A
2023-11-27 19:04C:RKVRakovina Therapeutics Inc0.07SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-11-27 12:59C:RKVRakovina Therapeutics Inc0.07News ReleaseRakovina appoints Cherkasov as scientific adviser
2023-11-20 14:25C:RKVRakovina Therapeutics Inc0.075News ReleaseRakovina appoints Hamerlik as scientific adviser
2023-08-29 17:44C:RKVRakovina Therapeutics IncSEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-08-29 17:38C:RKVRakovina Therapeutics IncSEDAR Interim MD & ASEDAR Interim MD & A
2023-08-29 13:45C:RKVRakovina Therapeutics Inc0.105News ReleaseRakovina spends $391,969 on R&D in Q2 2023
2023-06-29 00:01C:RKVRakovina Therapeutics Inc0.135News ReleaseRakovina shareholders re-elect four directors at AGM
2023-06-14 18:33C:RKVRakovina Therapeutics Inc0.135Private Placement - DebentureRakovina $1,514,000 debenture private placement
2023-05-31 14:03C:RKVRakovina Therapeutics Inc0.13News ReleaseRakovina spends $433,344 on R&D in Q1 2023
2023-05-30 21:36C:RKVRakovina Therapeutics Inc0.13SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2023-05-30 21:36C:RKVRakovina Therapeutics Inc0.13SEDAR MD & ASEDAR MD & A
2023-05-29 21:03C:RKVRakovina Therapeutics Inc0.13News ReleaseRakovina closes $1.5-million debenture financing